Shengkui Tan

766 total citations
54 papers, 482 citations indexed

About

Shengkui Tan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shengkui Tan has authored 54 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Shengkui Tan's work include RNA modifications and cancer (11 papers), Ferroptosis and cancer prognosis (10 papers) and Chemokine receptors and signaling (10 papers). Shengkui Tan is often cited by papers focused on RNA modifications and cancer (11 papers), Ferroptosis and cancer prognosis (10 papers) and Chemokine receptors and signaling (10 papers). Shengkui Tan collaborates with scholars based in China, United States and Australia. Shengkui Tan's co-authors include Xiaonian Zhu, Chunhua Bei, Chao Tan, Linyuan Qin, Xiaoqiang Qiu, Hongping Yu, Ren Yuan, Shidong Zhang, Xiaoqiang Qiu and Xiaoyun Zeng and has published in prestigious journals such as PLoS ONE, Journal of Ethnopharmacology and Carcinogenesis.

In The Last Decade

Shengkui Tan

48 papers receiving 476 citations

Peers

Shengkui Tan
Haijing Fu China
Weisi Liu China
Ping Zhan China
Kamilla E. Jensen Denmark
Cristina Cirauqui Spain
Selena Y. Lin United States
Núria Baixeras Spain
Emily Schonfeld United States
Indu Kohaar United States
Klaudia Szymonowicz United States
Haijing Fu China
Shengkui Tan
Citations per year, relative to Shengkui Tan Shengkui Tan (= 1×) peers Haijing Fu

Countries citing papers authored by Shengkui Tan

Since Specialization
Citations

This map shows the geographic impact of Shengkui Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengkui Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengkui Tan more than expected).

Fields of papers citing papers by Shengkui Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengkui Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengkui Tan. The network helps show where Shengkui Tan may publish in the future.

Co-authorship network of co-authors of Shengkui Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Shengkui Tan. A scholar is included among the top collaborators of Shengkui Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengkui Tan. Shengkui Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yuanyuan, Yue Tang, Li Xu, et al.. (2025). Dihydroartemisinin alleviates diethylnitrosamine-induced hepatocarcinogenesis by targeting a novel MAZ/TRIM50 axis. International Immunopharmacology. 156. 114733–114733.
2.
3.
Ding, Kai, Xiaowen He, Yi Gou, et al.. (2025). Scutellarin alleviates ferroptosis in cigarette smoke-induced chronic obstructive pulmonary disease via activation of the PI3K/AKT/Nrf2 signaling pathway. Journal of Ethnopharmacology. 357. 120870–120870. 1 indexed citations
4.
Zhang, Rongcheng, Zhongqi Zhang, Di Li, et al.. (2024). REXO2 up-regulation is positively correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. International Immunopharmacology. 130. 111740–111740. 4 indexed citations
5.
Li, Di, et al.. (2024). Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 11. 2493–2504. 3 indexed citations
6.
Zhang, Zhongqi, et al.. (2024). Predicting colorectal cancer risk: a novel approach using anemia and blood test markers. Frontiers in Oncology. 14. 1347058–1347058. 5 indexed citations
7.
Li, Juntong, Guanghua Lan, Shengkui Tan, et al.. (2024). The Distribution and Associated Factors of HIV/AIDS Among Youths in Guangxi, China, From 2014 to 2021: Bayesian Spatiotemporal Analysis. JMIR Public Health and Surveillance. 10. e53361–e53361.
8.
9.
Wu, Hongmei, Shidong Zhang, Run Tian, et al.. (2023). Myc-Associated Zinc Finger Protein Promotes Metastasis of Papillary Thyroid Cancer. Frontiers in Bioscience-Landmark. 28(8). 162–162. 7 indexed citations
10.
Wang, Na, Guanghua Lan, Qiuying Zhu, et al.. (2022). HIV Epidemiology, Care, and Treatment Outcomes Among Student and Nonstudent Youths Living With HIV in Southwest China Between 1996 and 2019: Historical Cohort Study. JMIR Public Health and Surveillance. 9. e38881–e38881. 3 indexed citations
11.
Zhu, Xiaonian, et al.. (2022). Hb New York, preliminary results concerning the hematologic characteristics and the effects on thalassemia. Molecular Biology Reports. 49(7). 6199–6205. 1 indexed citations
12.
Zhang, Shidong, Di Li, Chunhua Bei, et al.. (2020). Clinical Significance of POM121 Expression in Lung Cancer. Genetic Testing and Molecular Biomarkers. 24(12). 819–824. 5 indexed citations
13.
Tian, Run, Shidong Zhang, Chunhua Bei, et al.. (2020). M6A Demethylase FTO Plays a Tumor Suppressor Role in Thyroid Cancer. DNA and Cell Biology. 39(12). 2184–2193. 28 indexed citations
14.
Zhu, Xiaonian, Shidong Zhang, Shengkui Tan, et al.. (2020). Expression of CMTM4 shows clinical significance in lung cancer. Translational Cancer Research. 9(10). 6214–6220. 5 indexed citations
15.
Zhu, Xiaonian, Cong Li, Wen Zeng, et al.. (2019). Downregulated Expression of Chromobox Homolog 7 in Hepatocellular Carcinoma. Genetic Testing and Molecular Biomarkers. 23(5). 348–352. 9 indexed citations
16.
Zhu, Xiaonian, Zhigang Wang, Xiaoqiang Qiu, et al.. (2018). Rs2303428 of MSH2 Is Associated with Hepatocellular Carcinoma Prognosis in a Chinese Population. DNA and Cell Biology. 37(7). 634–641. 17 indexed citations
17.
Zhu, Xiaonian, Cong Li, Chunhua Bei, et al.. (2018). Expression and Clinical Significance of CMTM6 in Hepatocellular Carcinoma. DNA and Cell Biology. 38(2). 193–197. 43 indexed citations
18.
Bei, Chunhua, Ying Zhang, Xiaonian Zhu, et al.. (2017). Clinical significance of CMTM4 expression in hepatocellular carcinoma. OncoTargets and Therapy. Volume 10. 5439–5443. 26 indexed citations
19.
Zhu, Xiaonian, Meng Yan, Wei Luo, et al.. (2016). Expression and clinical significance of PcG-associated protein RYBP in hepatocellular carcinoma. Oncology Letters. 13(1). 141–150. 10 indexed citations
20.
Tan, Chao, Shun Liu, Shengkui Tan, et al.. (2015). Polymorphisms in MicroRNA Target Sites of Forkhead Box O Genes Are Associated with Hepatocellular Carcinoma. PLoS ONE. 10(3). e0119210–e0119210. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haijing Fu Breakdown of academic impact, for papers by Weisi Liu Breakdown of academic impact, for papers by Ping Zhan Breakdown of academic impact, for papers by Kamilla E. Jensen Breakdown of academic impact, for papers by Cristina Cirauqui Breakdown of academic impact, for papers by Selena Y. Lin Breakdown of academic impact, for papers by Núria Baixeras Breakdown of academic impact, for papers by Emily Schonfeld Breakdown of academic impact, for papers by Indu Kohaar Breakdown of academic impact, for papers by Klaudia Szymonowicz
Rankless by CCL
2026